BeyondSpring Inc. (BYSI)
NASDAQ: BYSI · Real-Time Price · USD
1.290
+0.010 (0.78%)
Jul 17, 2026, 4:00 PM EDT - Market closed
BeyondSpring Market Cap
BeyondSpring has a market cap or net worth of $53.04 million as of July 20, 2026. Its market cap has decreased by -40.47% in one year.
Market Cap
53.04M
Enterprise Value
45.43M
1-Year Change
-40.47%
Ranking
Category
Stock Price
$1.29
ChartMarket Cap Chart
Since March 9, 2017, BeyondSpring's market cap has decreased from $362.10M to $53.04M, a decrease of -85.35%. That is a compound annual growth rate of -18.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 53.00M | -19.33% |
| Dec 31, 2025 | 65.70M | - |
| Dec 31, 2024 | 65.70M | 87.18% |
| Dec 29, 2023 | 35.10M | -52.05% |
| Dec 30, 2022 | 73.20M | -58.71% |
| Dec 31, 2021 | 177.30M | -52.38% |
| Dec 31, 2020 | 372.30M | -7.48% |
| Dec 31, 2019 | 402.40M | -4.76% |
| Dec 31, 2018 | 422.50M | -32.59% |
| Dec 29, 2017 | 626.80M | 73.10% |
| Mar 9, 2017 | 362.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Boundless Bio | 55.71M |
| Context Therapeutics | 55.13M |
| Veraxa Biotech AG | 54.97M |
| Xilio Therapeutics | 53.13M |
| MiNK Therapeutics | 53.11M |
| Seres Therapeutics | 51.62M |
| Immutep | 51.45M |
| Filana Therapeutics | 51.21M |